Effectiveness of Health Literacy Program for Polypharmacy Patients (HLP-CKD)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Health Literacy Promotion Program (HLP-CKD).
- Who it may be relevant to
- Registry conditions: Chronic Kidney Diseases, Polypharmacy, Health Literacy. Basic parameters: 55 years — 74 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Thailand
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effectiveness of the Health Literacy Promotion Program to Prevent Chronic Kidney Disease of Patients Who Use Polypharmacy
Overview
This study aims to evaluate the effectiveness of a health literacy promotion program in preventing chronic kidney disease (CKD) among patients who use multiple medications (polypharmacy). Participants will be divided into two groups: an experimental group receiving the health literacy program and a control group receiving standard care. The study will measure improvements in health literacy levels and CKD prevention behaviors over a specific period. It is expected that the program will help patients better manage their medications and reduce the risk of developing kidney complications.
Detailed description
Background: Patients with polypharmacy are at a higher risk of drug-induced kidney injury. Enhancing health literacy is a key strategy to empower these patients to engage in protective health behaviors.
Objectives: 1) To compare health literacy scores before and after participating in the program. 2) To compare CKD prevention behaviors between the experimental and control groups.
Methodology: This is a quasi-experimental study with a pre-test/post-test design.
Experimental Group: Receives the "Health Literacy Promotion Program," which includes educational sessions, skill-building for medication management, and follow-up support.
Control Group: Receives routine nursing care and standard health education. Intervention Details: The program focuses on 6 aspects of health literacy: access, understanding, communication, questioning, decision-making, and practice.
Data Collection: Data will be collected using validated questionnaires for health literacy and CKD prevention behavior at baseline and after the intervention (e.g., at week 12).
Analysis: Descriptive statistics and t-tests (Independent and Paired) will be used to evaluate the program's effectiveness.
Interventions
- Behavioral Health Literacy Promotion Program (HLP-CKD)
An 8-week program consisting of educational sessions, skill-building for medication management, and follow-up support to prevent chronic kidney disease.
Primary outcome measures
- Health Literacy Levels [Time frame: Baseline, 8 weeks (immediately after intervention), and 12 weeks (follow-up).]
- CKD Prevention Behaviors [Time frame: Baseline, 8 weeks, and 12 weeks.]
Secondary outcome measures (3)
- Estimated Glomerular Filtration Rate (eGFR) [Time frame: Baseline and 12 weeks (follow-up)]
- Serum Creatinine [Time frame: Baseline and 12 weeks (follow-up)]
- Urine Albumin-to-Creatinine Ratio (UACR) [Time frame: Baseline and 12 weeks (follow-up).]
Eligibility criteria
Inclusion criteria
- Patients aged 55-74 years diagnosed with non-communicable diseases.
- Currently taking 5 or more medications daily (Polypharmacy) for at least 6 months.
- Have at least one risk factor for chronic kidney disease (e.g., Hypertension or Diabetes).
- Able to communicate, read, and write in Thai.
- Willing to participate in the 8-week program and follow-up assessments.
Exclusion criteria
- Patients already diagnosed with Chronic Kidney Disease (CKD) stage 3 - 5.
- Having severe cognitive impairment or psychiatric disorders that prevent participation.
- Having severe complications or being in an unstable clinical condition.
- Planning to move out of the study area during the 12-week study period.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Prevention
Study locations
Thailand · 1 center
- Health Promoting Hospital — Nakhon Pathom
Identifiers
NCT: NCT07622134 · 009/2026 · 012/2024